Benign Growth For Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Underpins Stock's 29% Plummet

The Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) share price has fared very poorly over the last month, falling by a substantial 29%. Still, a bad month hasn't completely ruined the past year with the stock gaining 94%, which is great even in a bull market.

Following the heavy fall in price, given about half the companies in India have price-to-earnings ratios (or "P/E's") above 25x, you may consider Indraprastha Medical as an attractive investment with its 20.7x P/E ratio. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's limited.

Indraprastha Medical certainly has been doing a good job lately as it's been growing earnings more than most other companies. It might be that many expect the strong earnings performance to degrade substantially, which has repressed the P/E. If not, then existing shareholders have reason to be quite optimistic about the future direction of the share price.

Check out our latest analysis for Indraprastha Medical

Want the full picture on analyst estimates for the company? Then our free report on Indraprastha Medical will help you uncover what's on the horizon.

What Are Growth Metrics Telling Us About The Low P/E?

In order to justify its P/E ratio, Indraprastha Medical would need to produce sluggish growth that's trailing the market.

Taking a look back first, we see that the company grew earnings per share by an impressive 34% last year. The latest three year period has also seen an excellent 158% overall rise in EPS, aided by its short-term performance. Therefore, it's fair to say the earnings growth recently has been superb for the company.

Turning to the outlook, the next year should generate growth of 18% as estimated by the sole analyst watching the company. That's shaping up to be materially lower than the 25% growth forecast for the broader market.

With this information, we can see why Indraprastha Medical is trading at a P/E lower than the market. Apparently many shareholders weren't comfortable holding on while the company is potentially eyeing a less prosperous future.

What We Can Learn From Indraprastha Medical's P/E?

Indraprastha Medical's recently weak share price has pulled its P/E below most other companies. Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.

We've established that Indraprastha Medical maintains its low P/E on the weakness of its forecast growth being lower than the wider market, as expected. At this stage investors feel the potential for an improvement in earnings isn't great enough to justify a higher P/E ratio. It's hard to see the share price rising strongly in the near future under these circumstances.

You always need to take note of risks, for example - Indraprastha Medical has 1 warning sign we think you should be aware of.

Of course, you might also be able to find a better stock than Indraprastha Medical. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.